UK Life Sciences Sector at Risk of Slipping Behind Rivals

Although the United Kingdom’s life sciences industry ranks third among industrialized nations in terms of spending, a recently released report shows that the nation is lagging behind on other important measures. For example, trial setup in the UK takes longer than the approval process, putting the nation behind other European countries like Germany and Switzerland in the number of therapeutics approved.

According to Phil Taylor, “In the UK, the set-up and recruitment of patients takes longer than the approval process, says the report. It also notes that comparator countries in Europe – such as Germany, the Netherlands and Switzerland – approved a greater number of innovative medicines in 2020 and took a shorter time to do so compared to both England and Scotland.”

To read more, click here.

(Source: PharmaPhorum, July 22nd, 2022)